Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by dredredre79on Jan 26, 2015 9:06pm

127 Views

Post# 23365864

Photofrin vs our PDCs

So our PDCs are almost 200 times better than already FDA approved photogenic. Wowza

This PDT effect has been translated effectively to animals and has proven superior to FDA approved PDC Photofrin®, in this research. The ability to activate the Theralase PDCs from visible to Near Infra Red (“NIR”) light marks an unprecedented versatility that can be exploited to match treatment depth to tumour target depth, giving rise to PDCs for multi-wavelength activated PDT, that can target superficial as well as deep seated tumours. - See more at: https://thenewswire.ca/archives?tnwcatalyst2=release_id%3D15260#sthash.56Zi4391.dpuf

Bullboard Posts

Global Tungsten Market and Supply Security